The present invention relates to a new process for the manufacture of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1H-indole-5-carbonitrile as a free base and pharmaceutically acceptable salts thereof, particularly the 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1H-indole-5-carbonitrile citrate, and to new intermediates prepared in said process suitable for large scale manufacturing of said compound.
本发明涉及一种制备2-羟基-3-[5-(
吗啡啉-4-基甲基)
吡啶-2-基]1H-
吲哚-5-羧腈及其自由碱和药学上可接受的盐的新工艺,特别是2-羟基-3-[5-(
吗啡啉-4-基甲基)
吡啶-2-基]1H-
吲哚-5-羧腈
柠檬酸盐,并涉及在该工艺中制备的新中间体,适用于大规模制造该化合物。